🇺🇸 FDA
Patent

US 8779156

Analogues for the treatment or prevention of flavivirus infections

granted A61PA61P31/12A61P31/14

Quick answer

US patent 8779156 (Analogues for the treatment or prevention of flavivirus infections) held by Vertex Pharmaceuticals Incorporated expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61P, A61P31/12, A61P31/14